Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (331-340 of 610) with videos related to

Pageof 61
Sort By:
Thrombosis Research|December 2, 2019
Procoagulant imbalance in preterm neonates detected by thrombin generation proceduresArmando Tripodi, Genny Raffaeli, Erica Scalambrino, et al.
International Journal of Laboratory Hematology|January 12, 2021
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levelsMarco Capecchi, Erica Scalambrino, Samantha Griffini, et al.
Thrombosis and Haemostasis|January 9, 2015
Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) projectKathelijn Fischer, Riita Lassila, Flora Peyvandi, et al.
Health Services Management Research|February 14, 2024
Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of HemophiliaStefano Villa, Raimondo De Cristofaro, Giovanni Di Minno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapyAna Boban, Fariba Baghaei, Fijnvandraat Karin, et al.
British Journal of Haematology|December 14, 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia AFlora Peyvandi, Syna Miri, Paolo Bucciarelli, et al.
BMJ Open|June 2, 2019
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE studyJohannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2024
Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part BAntonio Coppola, Flora Peyvandi, Laura Banov, et al.
Annals of Hematology|September 2, 2008
Factor XI deficiency in Southern Iran: identification of a novel missense mutationMehran Karimi, Hamta Jafari, Saba Lahsaeizadeh, et al.
Thrombosis Research|May 7, 2020
Pulmonary embolism in a young pregnant woman with COVID-19Ida Martinelli, Enrico Ferrazzi, Alessandro Ciavarella, et al.
Pageof 61

Showing results (331-340 of 610) with videos related to

Sort By:
Pageof 61
Thrombosis Research|December 2, 2019
Procoagulant imbalance in preterm neonates detected by thrombin generation proceduresArmando Tripodi, Genny Raffaeli, Erica Scalambrino, et al.
International Journal of Laboratory Hematology|January 12, 2021
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levelsMarco Capecchi, Erica Scalambrino, Samantha Griffini, et al.
Thrombosis and Haemostasis|January 9, 2015
Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) projectKathelijn Fischer, Riita Lassila, Flora Peyvandi, et al.
Health Services Management Research|February 14, 2024
Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of HemophiliaStefano Villa, Raimondo De Cristofaro, Giovanni Di Minno, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapyAna Boban, Fariba Baghaei, Fijnvandraat Karin, et al.
British Journal of Haematology|December 14, 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia AFlora Peyvandi, Syna Miri, Paolo Bucciarelli, et al.
BMJ Open|June 2, 2019
Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE studyJohannes Oldenburg, Charles R M Hay, Víctor Jiménez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2024
Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part BAntonio Coppola, Flora Peyvandi, Laura Banov, et al.
Annals of Hematology|September 2, 2008
Factor XI deficiency in Southern Iran: identification of a novel missense mutationMehran Karimi, Hamta Jafari, Saba Lahsaeizadeh, et al.
Thrombosis Research|May 7, 2020
Pulmonary embolism in a young pregnant woman with COVID-19Ida Martinelli, Enrico Ferrazzi, Alessandro Ciavarella, et al.
Pageof 61